853 related articles for article (PubMed ID: 29439314)
41. Long non-coding RNA MALAT-1 is downregulated in preeclampsia and regulates proliferation, apoptosis, migration and invasion of JEG-3 trophoblast cells.
Chen H; Meng T; Liu X; Sun M; Tong C; Liu J; Wang H; Du J
Int J Clin Exp Pathol; 2015; 8(10):12718-27. PubMed ID: 26722461
[TBL] [Abstract][Full Text] [Related]
42. Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer.
Yang T; Zhang W; Wang L; Xiao C; Guo B; Gong Y; Liang X; Huang D; Li Q; Nan Y; Xiang Y; Shao J
J Int Med Res; 2019 Jan; 47(1):481-493. PubMed ID: 30556447
[TBL] [Abstract][Full Text] [Related]
43. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
44. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
Wei S; Wang K; Huang X; Zhao Z; Zhao Z
Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
[TBL] [Abstract][Full Text] [Related]
45. Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer.
Schmidt LH; Görlich D; Spieker T; Rohde C; Schuler M; Mohr M; Humberg J; Sauer T; Thoenissen NH; Huge A; Voss R; Marra A; Faldum A; Müller-Tidow C; Berdel WE; Wiewrodt R
J Thorac Oncol; 2014 Sep; 9(9):1294-304. PubMed ID: 25036876
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
[TBL] [Abstract][Full Text] [Related]
47. LncRNA MALAT-1 Elevates HMGB1 to Promote Autophagy Resulting in Inhibition of Tumor Cell Apoptosis in Multiple Myeloma.
Gao D; Lv AE; Li HP; Han DH; Zhang YP
J Cell Biochem; 2017 Oct; 118(10):3341-3348. PubMed ID: 28295550
[TBL] [Abstract][Full Text] [Related]
48. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
49. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
50. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
51. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
52. miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer.
Jiang L; Ge W; Geng J
Pathol Res Pract; 2019 Dec; 215(12):152705. PubMed ID: 31685299
[TBL] [Abstract][Full Text] [Related]
53. Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis.
Fu J; Cai H; Wu Y; Fang S; Wang D
Gene; 2020 Sep; 755():144886. PubMed ID: 32534055
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of TrxR2 suppressed NSCLC cell proliferation, metabolism and induced cell apoptosis through decreasing antioxidant activity.
Bu L; Li W; Ming Z; Shi J; Fang P; Yang S
Life Sci; 2017 Jun; 178():35-41. PubMed ID: 28414076
[TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA CCAT1 promotes human retinoblastoma SO-RB50 and Y79 cells through negative regulation of miR-218-5p.
Zhang H; Zhong J; Bian Z; Fang X; Peng Y; Hu Y
Biomed Pharmacother; 2017 Mar; 87():683-691. PubMed ID: 28088735
[TBL] [Abstract][Full Text] [Related]
56. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
Liao J; Dong LP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells.
Su Z; Wang K; Li R; Yin J; Hao Y; Lv X; Li J; Zhao L; Du Y; Li P; Zhang J
World J Surg Oncol; 2016 Feb; 14():57. PubMed ID: 26923134
[TBL] [Abstract][Full Text] [Related]
58. Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells.
Liang L; Hui K; Hu C; Wen Y; Yang S; Zhu P; Wang L; Xia Y; Qiao Y; Sun W; Fei J; Chen T; Zhao F; Yang B; Jiang X
J Exp Clin Cancer Res; 2019 Feb; 38(1):71. PubMed ID: 30755242
[TBL] [Abstract][Full Text] [Related]
59. NEAT 1 knockdown enhances the sensitivity of human non-small-cell lung cancer cells to anlotinib.
Gu G; Hu C; Hui K; Chen T; Zhang H; Jiang X
Aging (Albany NY); 2021 May; 13(10):13941-13953. PubMed ID: 33982669
[TBL] [Abstract][Full Text] [Related]
60. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
Yang D; Wang JJ; Li JS; Xu QY
Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]